Malaga, Spain - April 14, 2016 - Professor John A Kanis, Emeritus Professor in Human Metabolism, was announced the winner of the ESCEO Medal of Excellence. The prestigious award honours an academic who has contributed significantly to the field of osteoporosis and musculoskeletal science through original and outstanding scientific contributions.
ESCEO President Jean-Yves Reginster, Co-Chair of the World Congress, said, "I have had the privilege of collaborating with John Kanis for nearly two decades. Over this period, he contributed significantly to advances in the field including in the general management of osteoporosis and musculoskeletal disorders. As one of the bone field's most highly respected researchers and key opinion leaders, John Kanis continues a long career marked by outstanding and influential scientific scholarship."
Prof. John A. Kanis received his medical degree from the University of Edinburgh. After a MRC Clinical Research Fellow position at the Nuffield Orthopaedic Centre he became Wellcome Senior Research Fellow at the University of Oxford. He was then appointed Reader in Human Metabolism and Clinical Biochemistry at the University of Sheffield, where he is currently the Emeritus Professor in Human Metabolism. He is Editor of Osteoporosis International and serves on the editorial board of several journals. He is the author of more than 1200 papers, chapters and books on bone disease and metabolism. His current major interest is in the development of risk assessment algorithms and the formulation of practice guidelines in many regions of the world.
Professor Kanis stated: "It is an honour and privilege to receive this Award. It is also testimony to the hard work of so many excellent team members and collaborators who have contributed to our research programme, as well as the institutions that have provided such welcome support. We shall continue our efforts to understand the causes and develop preventive strategies against the consequences of osteoporosis and other disabling musculoskeletal conditions."
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016) :
Held jointly by IOF and ESCEO, the Congress is taking place in Malaga, Spain from April 14-17,2016 is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit http://www.
About IOF :
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.
About ESCEO :
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.